- 全部删除
您的购物车当前为空
Ibalizumab(TMB-355) 是一种人源化 IgG4 单克隆抗体,可作为 CD4 受体抑制, 通过与 CD4 受体结合来阻止 HIV-1进入细胞。Ibalizumab 具有抗HIV-1感染活性,可用于维持机体正常免疫功能。


为众多的药物研发团队赋能,
让新药发现更简单!
Ibalizumab(TMB-355) 是一种人源化 IgG4 单克隆抗体,可作为 CD4 受体抑制, 通过与 CD4 受体结合来阻止 HIV-1进入细胞。Ibalizumab 具有抗HIV-1感染活性,可用于维持机体正常免疫功能。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 7,890 | In stock | |
| 5 mg | ¥ 15,800 | In stock | |
| 10 mg | ¥ 21,300 | In stock | |
| 25 mg | ¥ 31,700 | In stock | |
| 50 mg | ¥ 42,800 | In stock | |
| 100 mg | ¥ 57,800 | In stock |
Ibalizumab 相关产品
| 产品描述 | Ibalizumab(TMB-355) is a humanized IgG4 monoclonal antibody that acts as a CD4 receptor inhibitor, blocking the entry of HIV-1 into cells by binding to the CD4 receptor.Ibalizumab has anti-HIV-1 infectious activity and may be used to maintain normal immune function. |
| 别名 | 艾巴利珠单抗, TNX-355, TMB-355 |
| 分子量 | 147.3 kDa |
| CAS No. | 680188-33-4 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容